Clovis Oncology, Inc.'s stock has declined approximately -95.51381% over the past 52 weeks. The 50-day moving average sits at 0.41, while the 200-day moving average is 1.22.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95.51381% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 1.22 |
| Average Volume (20 Days) | N/A |